Does LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN Cause Fatigue? 177 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 177 reports of Fatigue have been filed in association with LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (PLUVICTO). This represents 1.7% of all adverse event reports for LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN.
177
Reports of Fatigue with LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN
1.7%
of all LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN reports
18
Deaths
24
Hospitalizations
How Dangerous Is Fatigue From LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN?
Of the 177 reports, 18 (10.2%) resulted in death, 24 (13.6%) required hospitalization, and 4 (2.3%) were considered life-threatening.
Is Fatigue Listed in the Official Label?
Yes, Fatigue is listed as a known adverse reaction in the official FDA drug label for LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN.
What Other Side Effects Does LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN Cause?
General physical health deterioration (4,332)
Ill-defined disorder (3,600)
Death (1,179)
Disease progression (286)
Malignant neoplasm progression (251)
Laboratory test abnormal (233)
Prostatic specific antigen increased (212)
Anaemia (154)
Covid-19 (139)
Platelet count decreased (130)
What Other Drugs Cause Fatigue?
ADALIMUMAB (29,420)
LENALIDOMIDE (22,956)
ETANERCEPT (19,907)
METHOTREXATE (19,885)
RITUXIMAB (15,602)
PALBOCICLIB (15,190)
PREDNISONE (14,320)
TOCILIZUMAB (13,802)
TOFACITINIB (13,551)
INFLIXIMAB (13,473)
Which LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN Alternatives Have Lower Fatigue Risk?
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LUTETIUM OXODOTREOTIDE LU-177
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LUTROPIN ALFA
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LYMECYCLINE
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LYRICA
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LYSERGIDE